A Multicenter, Double-Blind, Active-Controlled, Parallel Group Study to Examine the Safety, Tolerability and Efficacy of Oral MK-0974 for the Long Term Treatment of Acute Migraine With or Without Aura

Trial Profile

A Multicenter, Double-Blind, Active-Controlled, Parallel Group Study to Examine the Safety, Tolerability and Efficacy of Oral MK-0974 for the Long Term Treatment of Acute Migraine With or Without Aura

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Telcagepant (Primary) ; Rizatriptan
  • Indications Migraine; Migraine with aura; Migraine without aura
  • Focus Adverse reactions; Registrational
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 04 Jul 2012 Company added in association field as reported by European Clinical Trials Database.
    • 04 Jul 2012 Additional trial locations added as reported by European Clinical Trials Database.
    • 10 Sep 2009 Results reported at the Joint Meeting of the 14th International Headache Congress & the 51st Annual Scientific Meeting of the American Headache Society (IHC/AHS 2009).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top